The new anticonvulsant, lamotrigine, is becoming an important tool in the treatment of bipolar disorder, including bipolar depression. Its efficacy in bipolar depression might be linked to its inhibition of serotonin uptake. We present the case of a female schizoaffective patient successfully treated with 400 mg of lamotrigine developing considerable genital disorder, a side effect well known from the treatment with selective serotonin reuptake inhibitors (SSRIs). We suggest that female genital disorder induced by high doses of lamotrigine is a serotoninergic side effect. Our case suggests that lamotrigine is capable of inducing female genital disorder. In our case this phenomenon Case Report seems to be related to the increase of dosage from 200 to 400 mg/day. Within 10 weeks of continued medication
Lamotrigine is a novel anticonvulsant known to block was completely new to the patient, during previous depressions she sodium channels leading to a decrease of presynaptic was always able to enjoy sexual intercourse.) Until the end of 3/98 glutamate release [1] and influencing calcium channels the dosage remained unchanged with no change of the reported ad- [2] . Recently, Southam et al. [3] have shown that in pre-verse effect. parations of rat or human tissue lamotrigine inhibits serotonin uptake. This possible SSRI-like mechanism might explain lamotrigine's efficacy in the treatment of bipolar Discussion depression [4] [5] [6] .
Our case suggests that lamotrigine is capable of inducing female genital disorder. In our case this phenomenon Case Report seems to be related to the increase of dosage from 200 to 400 mg/day. Within 10 weeks of continued medication
The 37-year-old patient was admitted to our department in 6/97 with 400 mg/day no reduction of this side effect was obwith a severe schizomanic episode. Since age 18 she was hospitalised served. Female genital disorder -as well as abnormal at least 40 times in different psychiatric hospitals because of a schizoaffective disorder with rapid cycling. Lamotrigine was started in 7/97 ejaculation in men -can be a typical side effect of SSRIs, and was initially well tolerated. A severe depression developed despite e.g. in a double-blind, placebo-controlled study of paroxe-200 mg of Lamictal Ô monotherapy with a serum concentration of tine in the treatment of panic disorder [7] 13 of 136 women 2.4 mg/l. When in 1/98 lamotrigine was increased to a serum concen-receiving paroxetine (10-40 mg) reported genital disorder tration of 5.1 mg/ml (400 mg Lamictal Ô ) the schizomanic episode to (with 0/47 in the placebo group). We suggest that lamotriwhich the patient had meanwhile switched was successfully ameliorgine's serotoninergic component that might be desirable ated and the patient was dismissed. Unfortunately, at this dosage a in the treatment of bipolar depression can also lead to considerable genital disorder developed, the patient did not only describe an extinction of her libido, she also described that touching of female genital disorder, a SSRI-typical adverse effect. 
